Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.

Emerging microbes & infections - 20 Jul 2016

Mao Qunying, Wang Yiping, Bian Lianlian, Xu Miao, Liang Zhenglun

Abstract excerpt

Enteroviruses (EVs) are the most common viral agents in humans. Although most infections are mild or asymptomatic, there is a wide spectrum of clinical manifestations that may be caused by EV infections with varying degrees of severity. Among these viruses, EV-A71 and coxsackievirus (CV) CV-A16 from group A EVs attract the most attention because they are responsible for hand, foot and mouth disease (HFMD). Other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Approval
Share to Encephalitis, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enterovirus

Share to Enterovirus A, Human

Share to Enterovirus B, Human

Share to Hand, Foot and Mouth Disease

Share to Myocarditis

Share to Vaccines, Inactivated

Source

Open in PubMed Open full text

Identifiers

PMID: 27436364
DOI: 10.1038/emi.2016.73
PMCID: PMC5141264

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.PMID 27436364Read ↗

Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.Semantic proximity Read ↗

National Epidemiology and Evolutionary History of Four Hand, Foot and Mouth Disease-Related Enteroviruses in China from 2008 to 2016.Semantic proximity Read ↗

Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine developmentSemantic proximity Read ↗

Impact of Coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan.Semantic proximity Read ↗

Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.Semantic proximity Read ↗

Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022Semantic proximity Read ↗

The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine DevelopmentSemantic proximity Read ↗

The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific RegionSemantic proximity Read ↗

Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in ChinaSemantic proximity Read ↗

Molecular epidemiology of enteroviruses associated with severe hand, foot and mouth disease in Shenzhen, China, 2014-2018.Semantic proximity Read ↗

Epidemiology and virologic investigation of human enterovirus 71 infection in the Republic of Korea from 2007 to 2012: a nationwide cross-sectional study.Semantic proximity Read ↗

Genotypes of the Enterovirus Causing Hand Foot and Mouth Disease in Shanghai, China, 2012-2013.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.